Just cool down
We have had great news as of late.
Can anybody tell me who can claim to have reduced CTC counts in a mTNBC cancer patient to Zero??
After 14 weeks?? And a second one with reduction and elimination of some tumors ?? and overall improvement on a very advanced condition ??
OK.
Then, please cool down and stop trying to overengineer the whole enchilada.
The necessary patients will be injected when they will be injected. And we will get the data when we get the data. And apply to BTD when the time comes. We need to walk the road to get there. Same with HIV and the rest of indications.
I also want as some of you the stock price to be $2+ at least right now, but, also understand that the world is more complex. There are 100's of flippers and shorts trying to tumble the SP, they don't care about what happens in a week's time or whether the drug does anything.
When I learned that the ZTC was still 0 at 14 weeks is is ALL I wanted to hear. Is pretty much the only thing that matters. Will wait for more (hopefully) confirming data and calmly see the SP ride.
A week more, a month more I don't really care ... Is Lero working?? I care
8
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Overview of Equity Inducement Awards Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a leading biopharmaceutical organization, has recently initiated equity inducement awards to welcome new talent to its dynamic team. This initiative demonstrates Madrigal's commitment to fostering a strong workforce geared towards tackling significant health challenges related to metabolic...
Continue Reading
Boston Metal Appoints Industry Leader Roy Harvey Boston Metal, a prominent technology company that is transforming the landscape of global metals production, has made a significant move by appointing Roy Harvey to its Board of Directors. This decision is pivotal as Boston Metal gears up for the commercial rollout of its groundbreaking Molten Oxide Electrolysis (MOE)...
Continue Reading
RBL LLC Partners with Carnrite Ventures for Biotech Growth RBL LLC, a leading biotech venture creation studio, is excited to announce a significant investment from Carnrite Ventures. This partnership aims to enhance the rapid development of their robust pipeline of innovative therapeutic companies. According to Paul Wotton, the managing partner at RBL, "Carnrite's...
Continue Reading
Introducing the OncoC4 and AcroImmune Merger OncoC4, Inc. has just announced a thrilling merger with AcroImmune, a strategic union that promises to significantly boost OncoC4's standing in the biopharmaceutical sector. This collaboration brings together two companies dedicated to pioneering advancements in cancer treatment, with a special focus on developing unique...
Continue Reading
Rezolve AI Excited About $30 Billion AI Investment Rezolve AI (NASDAQ: RZLV), well-known for its cutting-edge AI-driven commerce solutions, is enthusiastic about the recent announcement from Microsoft and BlackRock. These influential tech companies plan to invest $30 billion into AI infrastructure, a decision that could profoundly alter the landscape of the artificial...
Continue Reading